297 related articles for article (PubMed ID: 1099449)
1. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
Sallan SE; Zinberg NE; Frei E
N Engl J Med; 1975 Oct; 293(16):795-7. PubMed ID: 1099449
[TBL] [Abstract][Full Text] [Related]
2. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
4. Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
Schwartz RH; Beveridge RA
J Addict Dis; 1994; 13(1):53-65. PubMed ID: 7503819
[TBL] [Abstract][Full Text] [Related]
5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
7. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
[TBL] [Abstract][Full Text] [Related]
8. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
9. Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study.
Devine ML; Dow GJ; Greenberg BR; Holstein DW; Icaza L; Jue PY; Meyers FH; O'Brien E; Roberts CM; Rocchio GL
Clin Pharm; 1987 Apr; 6(4):319-22. PubMed ID: 2822339
[No Abstract] [Full Text] [Related]
10. delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
Kluin-Neleman JC; Neleman FA; Meuwissen OJ; Maes RA
Vet Hum Toxicol; 1979 Oct; 21(5):338-40. PubMed ID: 516362
[TBL] [Abstract][Full Text] [Related]
11. Nabilone: a potent antiemetic cannabinol with minimal euphoria.
Herman TS; Jones SE; Dean J; Leigh S; Dorr R; Moon TE; Salmon SE
Biomedicine; 1977 Dec; 27(9-10):331-4. PubMed ID: 606307
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
13. Antiemetics for patients treated with antitumor chemotherapy.
Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
[TBL] [Abstract][Full Text] [Related]
14. A survey of antiemetic use in children with cancer.
van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
[TBL] [Abstract][Full Text] [Related]
15. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
[TBL] [Abstract][Full Text] [Related]
16. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
17. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
Steele N; Gralla RJ; Braun DW; Young CW
Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
[TBL] [Abstract][Full Text] [Related]
20. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy.
Med Lett Drugs Ther; 1985 Nov; 27(701):97-8. PubMed ID: 2999571
[No Abstract] [Full Text] [Related]
[Next] [New Search]